# Aurinia Pharmaceuticals Inc.: Form 8-K, filed May 15, 2025

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: 8-K
- Filed: 2025-05-15
- Accepted by EDGAR: May 15, 2025, 16:06 ET
- Period: 2025-05-15
- Accession: 0001600620-25-000057
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000160062025000057/auph-20250515.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000160062025000057/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000160062025000057/auph-20250515.htm

Filed May 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001600620-25-000057. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.